Keytruda+Lenvima – Flight 1 – Gynecological Display Banners Therapeutic Spotlight – 566767
Across Gynecologic Cancer Risk Groups, SLN Biopsy Deemed Effective
Mar 30, 2022
Sentinel lymph node (SLN) biopsy can be regularly used in surgical staging among high-risk...
Gynecologic Cancer Survival Impacted By Race
Mar 15, 2022
Across histologies other than clear cell, Black women with stage 1 endometrial cancer experienced...
Preoperative PET/CT Predicts Uterine Tumor Characteristics
Feb 11, 2022
Preoperative PET/CT provided information on standardized uptake value (SUV) and volumetric...
Higher Coffee Consumption Tied to Lower Risk for Uterine Cancer
Jan 28, 2022
FRIDAY, Jan. 28, 2022 (HealthDay News) — Increased coffee intake is associated with a lower...
Real-World Outcomes in Advanced Gynecologic Cancer
Jan 20, 2022
Women with advanced/recurrent endometrial cancer, especially those with the non-endometrioid (type...
The Role of Long Noncoding in Uterine Cancer
Dec 24, 2021
The fact that long noncoding RNA (IncRNA) LSINCT5 plays a crucial role in a huge number of human...
Lymphatic Metastasis Patterns in Uterine Cancer
Dec 24, 2021
Explaining the characteristics and the prognostic importance of isolated para-aortic lymphatic metastasis of endometrial cancer was the main objective of this study. On the basis of the Surveillance, Epidemiology, and End...
The Need For Molecular Testing As Tumours Evolve In Patients with Recurrent Gynecological Cancer
Dec 23, 2021
A clinical, as well as a diagnostic challenge, is posed by both synchronous and metachronous tumors which are amplified when the uncommon neuroendocrine histology is shown by one of the samples. The researchers give an account...
